SP
PFE icon

Symmetry Partners’s Pfizer PFE Stock Holding History

Symmetry Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38,480
Closed -$1.08M – 395
2024
Q2 		$1.08M Sell
38,480
-9,184
-19% -$253K 0.06% 150
2024
Q1 		$1.32M Sell
47,664
-3,054
-6% -$84.7K 0.1% 135
2023
Q4 		$1.46M Sell
50,718
-9,990
-16% -$302K 0.08% 114
2023
Q3 		$2.01M Sell
60,708
-12,514
-17% -$443K 0.11% 93
2023
Q2 		$2.69M Buy
73,222
+16,497
+29% +$642K 0.14% 75
2023
Q1 		$2.31M Sell
56,725
-24,886
-30% -$1.07M 0.13% 89
2022
Q4 		$4.18M Buy
81,611
+27,397
+51% +$1.31M 0.25% 53
2022
Q3 		$2.37M Sell
54,214
-28,622
-35% -$1.39M 0.16% 73
2022
Q2 		$4.34M Buy
82,836
+30,844
+59% +$1.57M 0.29% 50
2022
Q1 		$2.69M Sell
51,992
-67,626
-57% -$3.51M 0.17% 70
2021
Q4 		$7.06M Buy
119,618
+74,000
+162% +$3.67M 0.45% 38
2021
Q3 		$1.93M Buy
45,618
+1,123
+3% +$49.8K 0.13% 108
2021
Q2 		$1.74M Hold
44,495
– – 0.12% 121
2021
Q1 		$1.61M Sell
44,495
-10,979
-20% -$390K 0.12% 121
2020
Q4 		$2.04M Sell
55,474
-128
-0.2% -$4.7K 0.16% 85
2020
Q3 		$1.94M Buy
+55,602
New +$1.95M 0.17% 82
2019
Q4 		– Sell
-9,381
Closed -$320K – 358
2019
Q3 		$320K Sell
9,381
-62,424
-87% -$2.27M 0.07% 246
2019
Q2 		$2.95M Hold
71,805
– – 0.6% 29
2019
Q1 		$2.89M Buy
71,805
+11,732
+20% +$470K 0.49% 29
2018
Q4 		$2.49M Buy
+60,073
New +$2.49M 0.63% 30

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Symmetry Partners's PFE Position: Q3 2024 in Review

Symmetry Partners sold out of Pfizer (PFE) in Q3 2024, closing a stake of 38,480 shares — an estimated $1.08M sold.

Symmetry Partners first reported a position in PFE in Q4 2018 and held it in 20 quarters. The position peaked at $7.06M in Q4 2021. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Symmetry Partners reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 38,480 Pfizer shares in Q3 2024, an estimated $1.08M.
  • Symmetry Partners first reported a position in Pfizer in Q4 2018 and held it in 20 quarters.
  • Symmetry Partners's Pfizer position peaked at $7.06M in Q4 2021.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.